Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xueping tablet vs tranexamic acid for abnormal uterine bleeding related to endometrial causes (AUB-E)
ChiCTR2100054158Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Xueping tablet in menstrual disorders (2 arms), sponsored by Tongji Hospital. Primary endpoint: Effective rate of clinical efficacy evaluation. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
Xueping tablet
03
Conditions
menstrual disorders
Beyond the preview
Go deeper on ChiCTR2100054158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054158.